β-elemene can be used as an inducer of iron apoptosis and the combination of cetuximab and β-elemene can be sensitive to KRAS mutant CRC cells by inducing ferroptosis and inhibiting EMT [48]. Here, KRAS is linked to colorectal carcinoma.